Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

ResMed Inc. (RMD.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
34.70+0.19 (+0.55%)
As of 04:10PM AEST. Market open.
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close34.51
Open34.60
Bid34.65 x 0
Ask34.76 x 0
Day's Range34.43 - 34.79
52 Week Range27.37 - 38.41
Volume1,600,168
Avg. Volume1,148,130
Market Cap50.926B
Beta (5Y Monthly)0.42
PE Ratio (TTM)34.42
EPS (TTM)1.01
Earnings DateN/A
Forward Dividend & Yield0.24 (0.69%)
Ex-Dividend DateMay 11, 2022
1y Target Est33.84
  • Zacks

    ResMed (RMD) Gains on Product Uptake Even as Expenses Rise

    The continued uptake of ResMed's (RMD) core non-invasive ventilation and life support ventilation solutions for COPD and neuromuscular disease is encouraging.

  • Simply Wall St.

    Calculating The Fair Value Of ResMed Inc. (NYSE:RMD)

    How far off is ResMed Inc. ( NYSE:RMD ) from its intrinsic value? Using the most recent financial data, we'll take a...

  • GlobeNewswire

    ResMed Announces Participation in the Bank of America Global Healthcare Conference

    SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bank of America Global Healthcare Conference on Wednesday, September 14, 2022, beginning at approximately 9:05 a.m. (British Summer Time) at the Bank of America Financial Centre in London. More information about this event, including a live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay wi

Advertisement
Advertisement